Christopher Upton

Array ( [id] => 16009391 [patent_doc_number] => 20200179538 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-06-11 [patent_title] => FUNCTIONALIZED NANOPARTICLES AND METHODS OF MAKING AND USING SAME [patent_app_type] => utility [patent_app_number] => 16/614975 [patent_app_country] => US [patent_app_date] => 2018-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23371 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -41 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16614975 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17435896 [patent_doc_number] => 11261208 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-03-01 [patent_title] => Compounds for use as iron(III) MRI contrast agents [patent_app_type] => utility [patent_app_number] => 16/615024 [patent_app_country] => US [patent_app_date] => 2018-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 30 [patent_no_of_words] => 15709 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 397 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16615024 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18084398 [patent_doc_number] => 11534505 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-12-27 [patent_title] => Triaryl methane composition, dye composition for ocular membrane dyeing [patent_app_type] => utility [patent_app_number] => 15/984311 [patent_app_country] => US [patent_app_date] => 2018-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8750 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15984311 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18012162 [patent_doc_number] => 11504436 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-11-22 [patent_title] => Biogenic hemin-based MRI contrast agents, and compositions and methods thereof [patent_app_type] => utility [patent_app_number] => 16/608838 [patent_app_country] => US [patent_app_date] => 2018-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 11 [patent_no_of_words] => 5522 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16608838 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16087113 [patent_doc_number] => 20200197543 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-06-25 [patent_title] => TUMOR-TARGETING, CLEARABLE HUMAN PROTEIN-BASED MRI NANOPROBES, AND COMPOSITIONS AND METHODS THEREOF [patent_app_type] => utility [patent_app_number] => 16/608837 [patent_app_country] => US [patent_app_date] => 2018-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7843 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16608837 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14881655 [patent_doc_number] => 10420848 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-09-24 [patent_title] => Methods for treating and diagnosing blinding eye diseases [patent_app_type] => utility [patent_app_number] => 15/978782 [patent_app_country] => US [patent_app_date] => 2018-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 40 [patent_no_of_words] => 30773 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15978782 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13551679 [patent_doc_number] => 20180327387 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-11-15 [patent_title] => Cyanine Compounds [patent_app_type] => utility [patent_app_number] => 15/976491 [patent_app_country] => US [patent_app_date] => 2018-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33175 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 385 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15976491 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15901225 [patent_doc_number] => 20200150131 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-05-14 [patent_title] => DIAGNOSTIC ADVANCED GLYCATION END-PRODUCT ANTIBODIES [patent_app_type] => utility [patent_app_number] => 16/610473 [patent_app_country] => US [patent_app_date] => 2018-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11630 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16610473 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17974410 [patent_doc_number] => 11491247 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-11-08 [patent_title] => Methods and reagents for tumor targeting with greater efficacy and less toxicity [patent_app_type] => utility [patent_app_number] => 16/610816 [patent_app_country] => US [patent_app_date] => 2018-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 10052 [patent_no_of_claims] => 59 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 174 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16610816 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17556009 [patent_doc_number] => 11312685 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-04-26 [patent_title] => Targeting nanoparticles [patent_app_type] => utility [patent_app_number] => 16/607554 [patent_app_country] => US [patent_app_date] => 2018-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 21 [patent_no_of_words] => 16193 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 467 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16607554 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15524937 [patent_doc_number] => 20200054774 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-02-20 [patent_title] => BIODEGRADABLE MICROSPHERES INCORPORATING RADIONUCLIDES [patent_app_type] => utility [patent_app_number] => 16/608976 [patent_app_country] => US [patent_app_date] => 2018-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4848 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -3 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16608976 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15512521 [patent_doc_number] => 10562835 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2020-02-18 [patent_title] => Method for producing thorium-226 [patent_app_type] => utility [patent_app_number] => 15/954924 [patent_app_country] => US [patent_app_date] => 2018-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 9 [patent_no_of_words] => 5732 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15954924 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16806180 [patent_doc_number] => 20210128733 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-05-06 [patent_title] => BIOORTHOGONAL COMPOSITIONS [patent_app_type] => utility [patent_app_number] => 16/603471 [patent_app_country] => US [patent_app_date] => 2018-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36201 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -42 [patent_words_short_claim] => 114 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16603471 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13475803 [patent_doc_number] => 20180289444 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-10-11 [patent_title] => MULTI-MODE IMAGING MARKERS [patent_app_type] => utility [patent_app_number] => 15/946479 [patent_app_country] => US [patent_app_date] => 2018-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15428 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -54 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15946479 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17496543 [patent_doc_number] => 11285227 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-03-29 [patent_title] => Trifunctional constructs with tunablepharmacokinetics useful in imaging and anti-tumor therapies [patent_app_type] => utility [patent_app_number] => 16/500380 [patent_app_country] => US [patent_app_date] => 2018-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 17 [patent_no_of_words] => 37646 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 233 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16500380 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13458001 [patent_doc_number] => 20180280543 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-10-04 [patent_title] => Compounds and Method for Imaging Cancer [patent_app_type] => utility [patent_app_number] => 15/944735 [patent_app_country] => US [patent_app_date] => 2018-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8248 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15944735 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16053373 [patent_doc_number] => 20200188541 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-06-18 [patent_title] => RADIOLABELED BIOMOLECULES AND THEIR USE [patent_app_type] => utility [patent_app_number] => 16/498264 [patent_app_country] => US [patent_app_date] => 2018-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20890 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -32 [patent_words_short_claim] => 186 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16498264 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15394021 [patent_doc_number] => 10537647 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-01-21 [patent_title] => Methods for treating and diagnosing blinding eye diseases [patent_app_type] => utility [patent_app_number] => 15/937263 [patent_app_country] => US [patent_app_date] => 2018-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 40 [patent_no_of_words] => 30742 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15937263 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13311525 [patent_doc_number] => 20180207299 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-07-26 [patent_title] => ORGAN PROTECTION IN PSMA-TARGETED RADIONUCLIDE THERAPY OF PROSTATE CANCER [patent_app_type] => utility [patent_app_number] => 15/934304 [patent_app_country] => US [patent_app_date] => 2018-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11559 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15934304 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13311297 [patent_doc_number] => 20180207185 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-07-26 [patent_title] => METHODS OF TREATING MYELODYSPLASTIC SYNDROMES WITH A COMBINATION THERAPY USING LENALIDOMIDE AND AZACITIDINE [patent_app_type] => utility [patent_app_number] => 15/926740 [patent_app_country] => US [patent_app_date] => 2018-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12526 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15926740 [rel_patent_id] =>[rel_patent_doc_number] =>)